Faricimab in neovascular AMD: first report of real-world outcomes in an independent retina clinic

Purpose Assess short-term real-world outcomes in neovascular aged-related macular degeneration (nAMD) treated with novel faricimab. Methods Retrospective case series of nine patients with nAMD (11 eyes) treated with faricimab between May and November 2022. Treatment-naïve patients and non-naïve pati...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Eye (London) 2023-10, Vol.37 (15), p.3282-3289
Hauptverfasser:	Stanga, Paulo Eduardo, Valentín-Bravo, Francisco Javier, Stanga, Sebastian Eduardo Francis, Reinstein, Ursula Inge, Pastor-Idoate, Salvador, Downes, Susan M.
Format:	Artikel
Sprache:	eng
Schlagworte:	692/699/3161/1626 692/700/565/1331 Acuity Aged Aged, 80 and over Angiogenesis Inhibitors - administration & dosage Angiogenesis Inhibitors - therapeutic use Diabetes Drug therapy Edema Eye Female Fluorescein Angiography Humans Intravitreal Injections Laboratory Medicine Macular degeneration Male Medicine Medicine & Public Health Middle Aged Monoclonal antibodies Oct-1 protein Ophthalmology Pharmaceutical Sciences/Technology Retina Retrospective Studies Surgery Surgical Oncology Tomography Tomography, Optical Coherence Treatment Outcome Vascular endothelial growth factor Vascular Endothelial Growth Factor A - antagonists & inhibitors Visual acuity Visual Acuity - physiology Wet Macular Degeneration - diagnosis Wet Macular Degeneration - drug therapy Wet Macular Degeneration - physiopathology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!